The Administrative Core is the functional infrastructure of the PSM-MCC Partnership that promotes cancer research, outreach, biobanking and training by providing oversight, organization and ongoing evaluation for the scientific and administrative aspects of the Partnership. Such oversight includes but is not limited to day-today administrative and financial oversight, coordination of activities, and logistical support and services. Administrative and coordinating activities will occur at both institutions, with continuous communications being one of the principal responsibilities of the Administrative Core. The Administrative Core will support all projects, cores and shared resources in the Developmental Core. The MCC Administrative Core will be led by Drs. Jack Pledger, Teresita Munoz-Antonia, and Scott Antonia. The PSM Administrative Core will be led by Drs.
J aim e Matta, Jose Torres-Ruiz, and Idhaliz Flores. These investigators led the U56 PSM-MCC Partnership Administrative Core. It is important to point out that the MCC and PSM leaders, Drs. William Dalton and Joxel Garcia, are both regularly apprised of developments within the Partnership. Furthermore, these two individuals are in direct communication with each other during face to- face meetings at the annual retreats. Each Administrative Core will have one Partnership Program Manager who will report directly to the respective Principal Investigators at each institution. The Program Managers will be responsible for scheduling and planning the internal meetings of investigators, internal advisors, and key project and shared-resources personnel. Additionally, the Program Managers will coordinate all aspects of the visits of the members of the Program Steering Committee to the annual meeting.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA163071-02
Application #
8551282
Study Section
Special Emphasis Panel (ZCA1-SRLB-H)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
2
Fiscal Year
2013
Total Cost
$435,664
Indirect Cost
$148,356
Name
Ponce School of Medicine
Department
Type
DUNS #
105742043
City
Ponce
State
PR
Country
United States
Zip Code
00732
Matta, Jaime; Morales, Luisa; Ortiz, Carmen et al. (2016) Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer. PLoS One 11:e0152422
de Jesus, Edelmarie Rivera; Isidro, Raymond A; Cruz, Myrella L et al. (2016) Adoptive Transfer of Dendritic Cells Expressing Fas Ligand Modulates Intestinal Inflammation in a Model of Inflammatory Bowel Disease. J Clin Cell Immunol 7:
Rivera, Y M; Vélez, H; Canales, J et al. (2016) When a Common Language Is Not Enough: Transcreating Cancer 101 for Communities in Puerto Rico. J Cancer Educ 31:776-783
Lynce, Filipa; Graves, Kristi D; Jandorf, Lina et al. (2016) Genomic Disparities in Breast Cancer Among Latinas. Cancer Control 23:359-372
Abreu-Delgado, Yamilka; Isidro, Raymond A; Torres, Esther A et al. (2016) Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease. World J Gastroenterol 22:3581-91
Encarnación, Jarline; Ortiz, Carmen; Vergne, Ralphdy et al. (2016) High DRC Levels Are Associated with Let-7b Overexpression in Women with Breast Cancer. Int J Mol Sci 17:
Castro, Eida M; Jiménez, Julio C; Quinn, Gwendolyn et al. (2015) Identifying clinical and support service resources and network practices for cancer patients and survivors in southern Puerto Rico. Support Care Cancer 23:967-75
Isidro, Raymond A; Isidro, Angel A; Cruz, Myrella L et al. (2015) Double immunofluorescent staining of rat macrophages in formalin-fixed paraffin-embedded tissue using two monoclonal mouse antibodies. Histochem Cell Biol 144:613-21
Sosa-García, Bernadette; Vázquez-Rivera, Viviana; González-Flores, Jonathan N et al. (2015) The Retinoblastoma Tumor Suppressor Transcriptionally Represses Pak1 in Osteoblasts. PLoS One 10:e0142406
Dutil, Julie; Golubeva, Volha A; Pacheco-Torres, Alba L et al. (2015) The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective. Breast Cancer Res Treat 154:441-53

Showing the most recent 10 out of 22 publications